Abstract
The field of left atrial appendage closure is growing rapidly. A host of new companies have introduced new closure devices. The devices seek to improve intraprocedur al, short-term, and long-term outcomes. This chapter will describe four devices and their current stages of preclinical and clinical trial development.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CE mark:
-
Conformité Européenne mark
- LAA:
-
Left atrial appendage
- mm:
-
Millimeter
- PET:
-
Polyethylene terephthalate
- PTFE:
-
Polytetrafluoroethylene
- PVA:
-
Polyvinylacetate
- TEE:
-
Transesophageal echocardiogram
References
Lam YY. A new left atrial appendage occluder (Lifetech LAmbre device) for stroke prevention in atrial fibrillation. Cardiovasc Revasc Med. 2013;14:134–6.
Lam YY, Yan BP, Doshi SK, et al. Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre device) in a canine model. Int J Cardiol. 2013;168:3996–4001.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gafoor, S. et al. (2016). Novel Percutaneous LAA Closure Devices in Clinical or Preclinical Trials. In: Saw, J., Kar, S., Price, M. (eds) Left Atrial Appendage Closure. Contemporary Cardiology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-16280-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-16280-5_16
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-16279-9
Online ISBN: 978-3-319-16280-5
eBook Packages: MedicineMedicine (R0)